Cell lines for studying Phosphoinositide Function
To enable better understanding of the role of phosphoinositides in basic cell and disease biology Horizon has knocked out a number of key genes involved in phosphoinositide metabolism that are expressed in HAP1 cells and non-essential.
Pathways Phosphoinositide
Phosphatidylinositol and Phosphoinositides are a minor component of plasma and intracellular membranes.
Pathways Phosphoinositide
Phosphatidylinositol and Phosphoinositides are a minor component of plasma and intracellular membranes. Lipid phosphatases and kinases can target the inositol group at the level of the hydroxyls situated in the positions 3, 4, and 5 generating a total of 7 phosphoinositides.
Many of these molecules have been identified as essential mediators of signal transduction in various cellular processes, even some of those initially thought to be simple intermediates. Deregulated phosphoinositide metabolism is linked to various human diseases and cancer.
Further research is necessary to elucidate the mechanism of action of phosphoinositides and the proteins involved in their metabolism in the wide range of cellular processes and compartments were they have been found.
Explore our popular knockout cell lines for studying Phosphoinositide Function
| ARF1 | MTMR14 | PIK3R1 | PIP5K1C |
| FIG4 | MTMR3 | PIK3R2 | PITPNB |
| INPP5E | MTMR4 | PIK3R3 | SYNJ1 |
| INPP5J | MTMR6 | PIK3R6 | SYNJ2 |
| INPP5K | MTMR7 | PIKFYVE | VAC14 |
| INPPL1 | OCRL | PIP4K2A | |
| MTM1 | PI4K2A | PIP4K2B | |
| MTMR1 | PI4K2B | PIP5K1A |
Order products
Human knockout HAP-1 cells
The single largest bank of isogenic cell lines with over 7,500 cell lines to choose from and trusted by academia, biotech, and pharma research labs.
Cancer-related cell lines
Choose from over 300 knock-in and knockout cell line models in many standard cancer cell lines such as DLD1, MCF10A, and HCT116.
Cas9 Stable Cell Lines
Simplify gene editing experiments with stably expressing Cas9 cell lines
CRISPRmod CRISPRa dCas9-VPR Stable Cell Lines
Streamline CRISPR activation experiments with stably expressing dCas9-VPR cell lines